RSS   Newsletter   Contact   Advertise with us

Oxford BioDynamics appoints two independent non-executive directors

Christian Fernsby | Oxford, United Kingdom | April 8, 2019
Oxford BioDynamicsOxford BioDynamics, a biotechnology company, announced the appointments of David Holbrook and Peter Pack to the board of directors as independent non-executive directors.
David Holbrook is a proven leader in business development and healthcare investing, with 30 years' experience in the life sciences sector.

Dr. Holbrook, a qualified physician and MBA graduate from Harvard Business School, has worked for a variety of companies, charities and academic institutions including: GlaxoSmithKline, Roche, Imperial College London and the University of Cambridge.

In addition to his non-executive directorship at OBD, Dr. Holbrook will continue in his roles as Head of Seed Funds at LifeArc, Senior Independent Director at Worldwide Healthcare Trust plc and Chairman of The Liver Group Charity.

Dr. Holbrook brings a wealth of healthcare investment expertise as a former General Partner and Head of Healthcare Investing at MTI Ventures LLP, and Director, Life Sciences at the Cambridge University Seed Fund.

Peter Pack, currently Chief Executive Officer of Crescendo Biologics, brings over 25 years' experience of successfully establishing and growing international life sciences companies.

Mr. Pack will shortly step down as CEO at Crescendo, continuing to serve the company as a senior advisor.

Previously, Mr. Pack has served on a number of Boards and has headed up companies with up to 400 employees in the role of CEO and Managing Director, including mtm laboratories AG, where as co-founder and CEO he was responsible for the development, production and commercialisation of in vitro diagnostics for population-wide screening of cervical cancer.

He is also a Board member of PolyPlus Transfections SA.

 LATEST MOVES FROM United Kingdom